Having lost my mother to metastatic colorectal cancer when I was eight years old, conquering cancer has been my life’s mission.
I recently joined Rutgers Cancer Institute of New Jersey after completing my residency, fellowship and chief fellowship at Rutgers Robert Wood Johnson Medical School. Prior to that I obtained my medical degree from the UMDNJ-School of Osteopathic Medicine, completed my Masters of Public Health at Rutgers University School of Public Health and my undergraduate degree at Duke University.
I see patients as part of the Gastrointestinal/Hepatobiliary Program and the Phase I/Investigational Therapeutics Program at Rutgers Cancer Institute. I consider my patients partners in decision making, and I work closely with a team of surgical oncologists, radiation oncologists, nurses, social workers, nutritionists, genetic specialists and others, in order to help them understand the multiple elements of their disease. I also consider the whole patient, placing an emphasis on quality of life, complementary therapies, and respect for their choices.
In addition to treating patients, I also conduct research in early phase clinical studies where I attempt to bring novel agents from the basic science research laboratories into the clinic to help advance the oncology field for my patients. My particular interests are in vaccine and oncolytic virus immunotherapies.
I am the author or co-author of several publications and reviews, a book chapter and several abstracts on several phase I studies, and the real-world experience with immunotherapy. I have had specialty research training through the Cancer Therapy Evaluation Program (CTEP) Advanced Drug Development Fellowship and the American Society of Clinical Oncology (ASCO)/American Association for Cancer Research (AACR) Workshop on Methods in Clinical Cancer Research. I am also a member of ASCO, AACR and the Society for Immunotherapy of Cancer (SITC), where I present current research at local, regional, and national forums.
Colon cancer, pancreatic cancer, hepatobiliary cancers, phase I clinical trials, translational research
- Conquer Cancer Foundation 2015 Oncology Trainee Travel Award
- Rutgers University-RWJMS Department of Medicine Residents and Fellows Research Day Winner, CTEP #8850: A Phase I Trial of Riluzole and Sorafenib in Patients with Advanced Solid Tumors
- Rutgers University-RWJMS Department of Medicine Residents and Fellows Research Day Winner, When Benign Tumors Mimic Malignancies: A Case of Lymphangiomatosis Masquerading as Metastatic Disease